Open AccessAn Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors
Author(s) -
S. Onali,
Daniela Pugliese,
Flavio Caprioli,
Ambrogio Orlando,
Livia Biancone,
Olga Maria Nardone,
Nicola Imperatore,
Gionata Fiorino,
Maria Cappello,
Anna Viola,
M.B. Principi,
Cristina Bezzio,
Annalisa Aratari,
Sonia Carparelli,
S. Mazzuoli,
Francesco Manguso,
Laurino Grossi,
Giorgia Bodini,
Davide Giuseppe Ribaldone,
Giammarco Mocci,
Agnese Miranda,
Luigi Minerba,
Agnese Favale,
Mauro Grova,
Ludovica Scucchi,
S. Segato,
Walter Fries,
Fabiana Castiglione,
Alessandro Armuzzi,
Massimo Fantini
Publication year - 2022
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/ajg.0000000000001773
Subject(s) - vedolizumab , medicine , ustekinumab , crohn's disease , faecal calprotectin , ulcerative colitis , retrospective cohort study , gastroenterology , inflammatory bowel disease , infliximab , surgery , calprotectin , disease